| Characteristic | Subgroup | DISTAN1 METASTASES FREE SURVIVAL |
||
|---|---|---|---|---|
| No DM (n = 31) | DM (n = 25) | p-value | ||
| Age | ≤ 50 | 9 | 9 | 0.805 |
| > 50 | 22 | 16 | ||
| Gender | F | 27 | 20 | 0.221 |
| M | 4 | 5 | ||
| Side | L | 19 | 19 | 0.138 |
| R | 12 | 6 | ||
| Weight loss | Y | 2 | 9 | 0.087 |
| N | 29 | 16 | ||
| Palpable mass | Y | 5 | 10 | 0.277 |
| N | 26 | 15 | ||
| Operation | Nephrectomy | 27 | 23 | 0.336 |
| Tumorectomy | 3 | 1 | (nephrectomy or tumorectomy vs. compartment) | |
| Compartment | 1 | 1 | ||
| Intracaval luminal extension | Y | 4 | 4 | 0.284 |
| N | 27 | 21 | ||
| Tumour size | ≤ 10 cm | 21 | 12 | 0.210 |
| > 10 cm | 7 | 7 | (≤ 10 cm vs. > 10 cm) | |
| Unknown | 3 | 6 | ||
| Grade | 1 | 4 | 2 | 0.131 (1 vs. 2 or 3) |
| 2 or 3 | 9 | 10 | ||
| Unknown | 18 | 13 | ||
| Margins | Negative | 10 | 5 | 0.815 (neg. vs. pos.) |
| Positive | 1 | 1 | ||
| Unknown | 20 | 19 | ||
| Mitoses/10hpf | <10 | 9 | 1 | 0.266 (<10 vs. ≥10) |
| ≥10 | 1 | 2 | ||
| Unknown | 21 | 22 | ||
| Neoadjuvant/adjuvant chemotherapy | Y | 5 | 6 | 0.683 |
| N | 26 | 19 | ||
| Neoadjuvant/adjuvant radiotherapy | Y | 5 | 5 | 0.087 |
| N | 26 | 20 | ||
DM = distant metastases; F = female; L = left; M = male; N = No; R = right; Y = Yes